Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Eline Van Overbeeke"'
Autor:
Steven Simoens, Khadidja Abdallah, Liese Barbier, Teresa Barcina Lacosta, Alessandra Blonda, Elif Car, Zilke Claessens, Thomas Desmet, Evelien De Sutter, Laurenz Govaerts, Rosanne Janssens, Teodora Lalova, Evelien Moorkens, Robbe Saesen, Elise Schoefs, Yannick Vandenplas, Eline Van Overbeeke, Ciska Verbaanderd, Isabelle Huys
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Background: Countries are struggling to provide affordable access to medicines while supporting the market entry of innovative, expensive products. This Perspective aims to discuss challenges and avenues for balancing health care system objectives of
Externí odkaz:
https://doaj.org/article/bbc0089204d243a890fa9366197ff0a6
Autor:
Rosanne Janssens, Isabelle Huys, Eline van Overbeeke, Chiara Whichello, Sarah Harding, Jürgen Kübler, Juhaeri Juhaeri, Antonio Ciaglia, Steven Simoens, Hilde Stevens, Meredith Smith, Bennett Levitan, Irina Cleemput, Esther de Bekker-Grob, Jorien Veldwijk
Publikováno v:
BMC Medical Informatics and Decision Making, Vol 19, Iss 1, Pp 1-16 (2019)
Abstract Background The inclusion of patient preferences (PP) in the medical product life cycle is a topic of growing interest to stakeholders such as academics, Health Technology Assessment (HTA) bodies, reimbursement agencies, industry, patients, p
Externí odkaz:
https://doaj.org/article/ae621afc397d4cdc862cb8d062cde3cf
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 14, Iss 1, Pp 1-11 (2019)
Abstract Background Late and misdiagnoses of rare disease patients are common and often result in medical, physical and mental burden for the patient, and financial and emotional burden for the patient’s family. Low rare disease awareness among phy
Externí odkaz:
https://doaj.org/article/d471a78c41ca4a99973569d4a3ba5ef3
Autor:
Eline van Overbeeke, Brett Hauber, Sissel Michelsen, Michel Goldman, Steven Simoens, Isabelle Huys
Publikováno v:
Frontiers in Medicine, Vol 8 (2021)
Introduction: Gene therapies are innovative therapies that are increasingly being developed. However, health technology assessment (HTA) and payer decision making on these therapies is impeded by uncertainties, especially regarding long-term outcomes
Externí odkaz:
https://doaj.org/article/b803d215a7674c1fa6f6d70cde56f4bf
Autor:
Aura Cecilia Jimenez-Moreno, Cathy Anne Pinto, Bennett Levitan, Chiara Whichello, Christine Dyer, Eline Van Overbeeke, Esther de Bekker-Grob, Ian Smith, Isabelle Huys, Jennifer Viberg Johansson, Kate Adcock, Kristin Bullock, Vikas Soekhai, Zhong Yuan, Hanns Lochmuller, Ardine de Wit, Grainne S. Gorman
Publikováno v:
Wellcome Open Research, Vol 5 (2020)
Objectives: Patient preference studies are increasingly used to inform decision-making during the medical product lifecycle but are rarely used to inform early stages of drug development. The primary aim of this study is to quantify treatment prefere
Externí odkaz:
https://doaj.org/article/8623bb03c25946aa94f4b7c872c29544
Autor:
Nenad Miljković, Eline van Overbeeke, Brian Godman, Milena Kovačević, Alison Anastasi, Tomasz Bochenek, Isabelle Huys, Branislava Miljković
Publikováno v:
Frontiers in Medicine, Vol 7 (2020)
Objective: This study aimed to obtain a comprehensive overview on the perception, attitudes, and experience of European pharmacists with prospective risk assessment procedures in everyday practice, as well as to identify challenges and solutions. Thi
Externí odkaz:
https://doaj.org/article/e4f35963f95746a191c10e6b75fbe5b9
Autor:
Nenad Miljković, Brian Godman, Eline van Overbeeke, Milena Kovačević, Karyofyllis Tsiakitzis, Athina Apatsidou, Anna Nikopoulou, Cristina Garcia Yubero, Laura Portillo Horcajada, Gunar Stemer, Darija Kuruc-Poje, Thomas De Rijdt, Tomasz Bochenek, Isabelle Huys, Branislava Miljković
Publikováno v:
Frontiers in Medicine, Vol 7 (2020)
Introduction: Medicine shortages result in great risk for the continuity of patient care especially for antimicrobial treatment, potentially enhancing resistance rates and having a higher economic impact. This study aims to identify, describe, assess
Externí odkaz:
https://doaj.org/article/f1f01f3d01af4f8da3620511def580bc
Publikováno v:
Frontiers in Medicine, Vol 7 (2020)
Objectives: A factor contributing to the value of patient preference studies is patient centricity. This study aimed to explore how patients want to be involved in the design and conduct of patient preference studies. In addition, we investigated pat
Externí odkaz:
https://doaj.org/article/f0150ac4e2514da19c5d680414e06db4
Autor:
Lynda Grine, Rosanne Janssens, Eline van Overbeeke, Danielle Derijcke, Mitchell Silva, Belinda Delys, Isabelle Dusart, Veerle Aertsen, Magali Mertens de Wilmars, Joanna Robaczewska, Hilde Stevens
Publikováno v:
Frontiers in Medicine, Vol 7 (2020)
EUPATI Belgium (EUPATI.be) is an informal gathering of local partners who are interested in improving patient involvement in healthcare innovation and medicines research and development. EUPATI.be brings together various stakeholders from different a
Externí odkaz:
https://doaj.org/article/0cc085f3d86e483dae9222a3d054fa41
Autor:
Eline van Overbeeke, Rosanne Janssens, Chiara Whichello, Karin Schölin Bywall, Jenny Sharpe, Nikoletta Nikolenko, Berkeley S. Phillips, Paolo Guiddi, Gabriella Pravettoni, Laura Vergani, Giulia Marton, Irina Cleemput, Steven Simoens, Jürgen Kübler, Juhaeri Juhaeri, Bennett Levitan, Esther W. de Bekker-Grob, Jorien Veldwijk, Isabelle Huys
Publikováno v:
Frontiers in Pharmacology, Vol 10 (2019)
Objectives: To investigate stakeholder perspectives on how patient preference studies (PPS) should be designed and conducted to allow for inclusion of patient preferences in decision-making along the medical product life cycle (MPLC), and how patient
Externí odkaz:
https://doaj.org/article/ff9cd1b9a3ba4748ac61b75bbee788e6